Oxford Asset Management’s Histogen Inc. Common Stock HSTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-258
Closed -$89K 2108
2018
Q4
$89K Buy
+258
New +$200K ﹤0.01% 1665
2018
Q2
Sell
-283
Closed -$333K 2000
2018
Q1
$333K Sell
283
-259
-48% -$286K 0.01% 1377
2017
Q4
$508K Buy
+542
New +$501K 0.01% 1172
2017
Q3
Sell
-200
Closed -$230K 1772
2017
Q2
$230K Buy
+200
New +$243K ﹤0.01% 1329
2016
Q1
Sell
-538
Closed -$299K 939
2015
Q4
$299K Buy
+538
New +$377K 0.01% 750

Other funds holding HSTO

Oxford Asset Management's HSTO Position: Q1 2019 in Review

Oxford Asset Management sold out of Histogen Inc. Common Stock (HSTO) in Q1 2019, closing a stake of 258 shares — an estimated $89K sold.

Oxford Asset Management first reported a position in HSTO in Q4 2015 and held it in 5 quarters. The position peaked at $508K in Q4 2017. 42 funds tracked by Wall St. Rank hold HSTO as of Q1 2019.

  • Oxford Asset Management reported no remaining Histogen Inc. Common Stock position as of Q1 2019 after selling out during the quarter.
  • Oxford Asset Management sold 258 Histogen Inc. Common Stock shares in Q1 2019, an estimated $89K.
  • Oxford Asset Management first reported a position in Histogen Inc. Common Stock in Q4 2015 and held it in 5 quarters.
  • Oxford Asset Management's Histogen Inc. Common Stock position peaked at $508K in Q4 2017.
  • 42 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q1 2019.

Based on Oxford Asset Management's 13F filing for Q1 2019, filed 15 May 2019.